Suppr超能文献

视网膜母细胞瘤动脉内化疗后脉络膜缺血对分水岭区的保护作用

Choroidal Ischemia Sparing the Watershed Zone following Intra-Arterial Chemotherapy for Retinoblastoma.

作者信息

Ancona-Lezama David Arturo, Dalvin Lauren A, Lucio-Alvarez J Antonio, Jabbour Pascal, Shields Carol L

机构信息

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Ocul Oncol Pathol. 2019 Apr;5(3):190-194. doi: 10.1159/000490856. Epub 2018 Sep 17.

Abstract

PURPOSE

Intra-arterial chemotherapy (IAC) has become a mainstay in the management of retinoblastoma, especially in advanced or refractory disease. However, IAC is not without complications, and chemotherapy toxic effects can lead to partial or complete choroidal ischemia, often causing vision loss.

METHODS

This is a case report.

RESULTS

A 4-month-old girl with bilateral retinoblastoma was treated with secondary IAC (melphalan 5 mg) for recurrent tumor following intravenous chemotherapy. One month later, complete tumor control was achieved. However, she demonstrated broad choroidal ischemia in the nasal and temporal quadrants but sparing of the watershed zone superior and inferior to the optic disc and in the papillomacular region. Fluorescein angiography revealed poor perfusion of the choriocapillaris with visibility of the large choroidal vessels in the nasal and temporal areas but preserved perfusion of the watershed zone. The watershed zone remained intact on the 10-month follow-up, and the final visual acuity was fix and follow without strabismus.

CONCLUSION

The pathophysiology of choroidal ischemia is not well understood, but the fortuitous watershed zone preservation in this case could represent uneven distribution of the chemotherapeutic drug, resulting in partial chemo-dilution of the medication in the watershed region, which represents the final downstream overlapping choroidal perfusion from both medial and lateral posterior ciliary arteries.

摘要

目的

动脉内化疗(IAC)已成为视网膜母细胞瘤治疗的主要手段,尤其是在晚期或难治性疾病中。然而,IAC并非没有并发症,化疗毒性作用可导致部分或完全性脉络膜缺血,常导致视力丧失。

方法

这是一例病例报告。

结果

一名4个月大的双侧视网膜母细胞瘤女孩在静脉化疗后因肿瘤复发接受了二次IAC(美法仑5mg)治疗。1个月后,肿瘤得到完全控制。然而,她在鼻侧和颞侧象限出现广泛的脉络膜缺血,但视盘上下及黄斑乳头区的分水岭区未受累。荧光素血管造影显示脉络膜毛细血管灌注不良,鼻侧和颞侧大脉络膜血管可见,但分水岭区灌注保留。在10个月的随访中,分水岭区保持完整,最终视力固定且无斜视。

结论

脉络膜缺血的病理生理学尚不完全清楚,但该病例中分水岭区的意外保留可能代表化疗药物分布不均,导致分水岭区域药物部分化学稀释,该区域代表来自睫状后内侧和外侧动脉的最终下游重叠脉络膜灌注。

相似文献

8
Watershed zone in the human peripheral choroid.
Ophthalmology. 1996 Feb;103(2):336-42. doi: 10.1016/s0161-6420(96)30695-7.
10
Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗后的组织病理学观察
Arch Ophthalmol. 2011 Nov;129(11):1416-21. doi: 10.1001/archophthalmol.2011.223. Epub 2011 Jul 11.

引用本文的文献

1
Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells.基于肿瘤细胞来源的视网膜母细胞瘤复发管理
Middle East Afr J Ophthalmol. 2024 Jan 22;30(1):24-30. doi: 10.4103/meajo.meajo_112_23. eCollection 2023 Jan-Mar.

本文引用的文献

1
A simple method to ensure homogeneous drug distribution during intrarenal infusion.一种确保肾内输注期间药物均匀分布的简单方法。
Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F543-F548. doi: 10.1152/ajprenal.00417.2016. Epub 2016 Nov 23.
5
Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗后的组织病理学观察
Arch Ophthalmol. 2011 Nov;129(11):1416-21. doi: 10.1001/archophthalmol.2011.223. Epub 2011 Jul 11.
9
Physiological anatomy of the choroidal vascular bed.脉络膜血管床的生理解剖学
Int Ophthalmol. 1983 Feb;6(2):85-93. doi: 10.1007/BF00127636.
10
The pathogenesis of watershed infarcts in the brain.
Stroke. 1984 Mar-Apr;15(2):221-3. doi: 10.1161/01.str.15.2.221.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验